ROCKWELL MEDICAL, INC.

RMTI · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 157 employees
355
SEC Filings
$0.7182
Close 2026-06-01
157
Employees

Business Summary

Rockwell Medical, Inc. is a healthcare company that develops, manufactures, commercializes, and distributes hemodialysis products for dialysis providers worldwide. The company supplies liquid and dry acid and bicarbonate concentrates for dialysis patients, primarily in the United States. Products are manufactured at facilities in Michigan and Texas under cGMP regulations and delivered to dialysis clinics via company trucks and third-party carriers. Rockwell serves 294 customers including all five leading U.S. dialysis providers.

Latest Stock Quote

RMTI 2026-06-01 $0.7182 O:$0.7408 H:$0.7435 L:$0.71 Vol:0.5M VWAP:$0.7204
origin leaf: 3647c6126602eaece48882cccd157032ee8b7cb5352c3a344a5d93492bcb8982

Next Earnings

Q2 FY2026 — expected 2026-09-14

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-262025-12-310001628280-26-021186EDGAR45K words
2025-03-202024-12-310001628280-25-013983EDGAR
2024-03-212023-12-310001628280-24-012572EDGAR
2023-03-302022-12-310001628280-23-009774EDGAR
2022-04-082021-12-310001628280-22-008830EDGAR
2021-03-312020-12-310001628280-21-006280EDGAR
2020-03-172019-12-310001628280-20-003683EDGAR
2019-03-182018-12-310001558370-19-002200EDGAR
2018-03-152017-12-310001558370-18-002142EDGAR
2017-03-152016-12-310001558370-17-001846EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001628280-25-051290EDGAR19K words
2025-08-142025-06-300001041024-25-000011EDGAR
2025-05-122025-03-310001628280-25-024434EDGAR
2024-11-122024-09-300001628280-24-046839EDGAR
2024-08-082024-06-300001628280-24-035859EDGAR
2024-05-142024-03-310001628280-24-023056EDGAR
2023-11-142023-09-300001628280-23-038781EDGAR
2023-08-142023-06-300001628280-23-029168EDGAR
2023-05-152023-03-310001628280-23-017994EDGAR
2022-11-142022-09-300001628280-22-029627EDGAR
2022-08-152022-06-300001628280-22-022899EDGAR
2022-05-162022-03-310001628280-22-014502EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-260001628280-26-021195EDGAR1K words
2026-03-260001628280-26-021176EDGAR
2026-01-200001628280-26-002478EDGAR
2026-01-050001628280-26-000221EDGAR
2025-11-180001104659-25-113452EDGAR
2025-11-120001628280-25-051311EDGAR
2025-11-120001628280-25-051267EDGAR
2025-09-290001104659-25-094524EDGAR
2025-08-140001041024-25-000009EDGAR
2025-05-200001104659-25-050997EDGAR

355 total filings indexed. 323 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

hemodialysis-concentrate-supply end-stage-kidney-disease-treatment freestanding-outpatient-dialysis-centers hospital-based-outpatient-dialysis-centers skilled-nursing-facilities home-dialysis international-dialysis-providers cgmp-(current-good-manufacturing-practices) aami-(association-for-the-advancement-of-medical-instrumentation)-guidelines fda-510(k)-approval

Company Identity

CIK0001041024
TickerRMTI
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
HeadquartersWixom, Michigan
Websitehttps://www.rockwellmed.com
Listed1998-01-27

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 5d1d1f2ef9344bf02911c7c3fdaa75f017a5cdbae9e478ceabbfc466e142cf04
parent: 24fe1331986b26fc029384db4f434bc7f3ce3b37d500c47977aae2f192830a0a
content hash: e1623314f9b08b5ba0f78c152d9dbd4abb5616b92547684b58f2c3cf4d13e5e3
signed: 2026-06-03T12:02:26.637Z
sources: 23 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf